CIDRAP-ASP Report – Bringing Value to the Care Pathway: The Rising Role of Rapid Diagnostics
22 September 2023
In the second of a three-part series, CIDRAP-ASP explores the role of outcomes research in making the value case for rapid diagnostics that help to identify infectious diseases and prevent antimicrobial resistance (AMR).
The report also features two case studies on the role of outcomes research in: 1) clarifying the cost-effectiveness of rapid diagnostics for sepsis in different health contexts and 2) evaluating the cost-effectiveness of rapid diagnostics for invasive fungal infections in people living with HIV in Guatemala.
Further reading: CIDRAP
Author(s): Francesca Chiara and Natalie Vestin
Effective Surveillance
OUR UNDERWRITERS
Unrestricted financial support by:
 |
LifeArc |
 |
Antimicrobial Resistance Fighter Coalition |
 |
Bangalore Bioinnovation Centre |
 |
INTERNATIONAL FEDERATION PHARMACEUTICAL MANUFACTURERS & ASSOCIATIONS |
AMR NEWS
Every two weeks in your inbox
Because there should be one newsletter that brings together all One Health news related to antimicrobial resistance: AMR NEWS!